Quick Overview: Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Stephan Grupp, MD, PhD, ... Krishna V. Komanduri, MD; David Maloney, MD, PhD; and Stephen J. Schuster, MD, describe the rationale for Elisabet Manasanch, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses a Phase I first-in-human ...
Car T Cells Targeting Bcma - Detailed Overview & Context
Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Stephan Grupp, MD, PhD, ... Krishna V. Komanduri, MD; David Maloney, MD, PhD; and Stephen J. Schuster, MD, describe the rationale for Elisabet Manasanch, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses a Phase I first-in-human ... Dr. Juan Du (Changzheng Hospital, Naval Medical University—Shanghai, China) provides updates on the study results of ... Parameswaran Hari, MD, MRCP, projects how B-cell maturation antigen ( Laurent Garderet, MD, from Hopital Saint-Antoine, Paris, France, talks
Ajai Chari, MD; C. Ola Landgren, MD, PhD; Pei Lin, MD; and Nina Shah, MD, describe the potential of B- Sagar Lonial, Winship Cancer Institute of Emory University, Atlanta, GA, discusses the promising results of anti- A. Keith Stewart, MB, ChB; Edward A. Stadtmauer, MD; Ajai Chari, MD; Thomas Martin, MD; and Amrita Krishnan, MD, review the ... Multiple myeloma (MM) is at the forefront of immunotherapeutic developments, including Alfred Garfall, MD, MS University of Pennsylvania, Pennsylvania, PA, discusses the latest results looking at anti- Hamza Hashmi, MD, Medical University of South Carolina, Charleston, SC, explains where
Website: Twitter: Facebook: LinkedIn: ... A one-time infusion of an investigational DocWire News sat down with Natalie Callander, MD, professor and director of the Myeloma Clinical Program at the University of ... Deepu Madduri, MD, Icahn School of Medicine at Mount Sinai, New York, NY, discusses the Phase Ib results from the ongoing ...
